Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein–Barr virus is unaffected by CpG methylation and does not correlate with Cp activity
In this study, the binding of the insulator protein CCCTC-binding factor (CTCF) to the region located between Rep* and the C promoter (Cp) of Epstein–Barr virus (EBV) was analysed using chromatin immunoprecipitation and in vivo footprinting. CTCF binding was found to be independent of Cp usage in cell lines corresponding to the major EBV latency types. Bisulfite sequencing and an electrophoretic mobility-shift assay (using methylated and unmethylated probes) revealed that CTCF binding was insufficient to induce local CpG demethylation in certain cell lines and was unaffected by CpG methylation in the region between Rep* and Cp. In addition, CTCF binding to the latency promoter, Qp, did not correlate with Qp activity.
AltiokE.,
MinarovitsJ.,
HuL. F.,
Contreras-BrodinB.,
KleinG.,
ErnbergI.1992; Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein–Barr virus nuclear antigens 2–6. Proc Natl Acad Sci U S A 89:905–909[CrossRef]
BakosA.,
BanatiF.,
KoroknaiA.,
TakacsM.,
SalamonD.,
Minarovits-KormutaS.,
SchwarzmannF.,
WolfH.,
NillerH. H.,
MinarovitsJ.2007; High resolution analysis of CpG methylation and in vivo protein–DNA interactions at the alternative Epstein–Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1. Virus Genes 35:195–202[CrossRef]
BanatiF.,
KoroknaiA.,
SalamonD.,
TakacsM.,
Minarovits-KormutaS.,
WolfH.,
NillerH. H.,
MinarovitsJ.2008; CpG-methylation silences the activity of the RNA polymerase III transcribed EBER-1 promoter of Epstein–Barr virus. FEBS Lett 582:705–709[CrossRef]
BussonP.,
GanemG.,
FloresP.,
MuqneretF.,
ClausseB.,
CaillouB.,
BrahamK.,
WakasugiH.,
LipinskiM.,
TurszT.1988; Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer 42:599–606[CrossRef]
ChauC. M.,
ZhangX. Y.,
McMahonS. B.,
LiebermanP. M.2006; Regulation of Epstein–Barr virus latency type by the chromatin boundary factor CTCF. J Virol 80:5723–5732[CrossRef]
CheungS. T.,
HuangD. P.,
HuiA. B.,
LoK. W.,
KoC. W.,
TsangY. S.,
WongN.,
WhitneyB. M.,
LeeJ. C.1999; Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein–Barr virus. Int J Cancer 83:121–126[CrossRef]
ErnbergI.,
FalkK.,
MinarovitsJ.,
BussonP.,
TurszT.,
MasucciM. G.,
KleinG.1989; The role of methylation in the phenotype-dependent modulation of Epstein–Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein–Barr virus. J Gen Virol 70:2989–3002[CrossRef]
FalkK. I.,
SzekelyL.,
AlemanA.,
ErnbergI.1998; Specific methylation patterns in two control regions of Epstein–Barr virus latency: the LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP). J Virol 72:2969–2974
FejerG.,
KoroknaiA.,
BanatiF.,
GyöryI.,
SalamonD.,
WolfH.,
NillerH. H.,
MinarovitsJ.2008; Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein–Barr virus. J Gen Virol 89:1364–1370[CrossRef]
GregoryC. D.,
RoweM.,
RickinsonA. B.1990; Different Epstein–Barr virus–B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 71:1481–1495[CrossRef]
JonesM. D.,
FosterL.,
SheedyT.,
GriffinB. E.1984; The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus. EMBO J 3:813–821
KavathasP.,
BachF. H.,
DeMarsR.1980; Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A 77:4251–4255[CrossRef]
LenoirG. M.,
VuillaumeM.,
BonnardelC.1985; The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. IARC Sci Publ 60:309–318
LiebowitzD.1998; Epstein–Barr virus pathogenesis. In Human Tumor Viruses . pp 173–199Edited byMcCance.
Washington, DC: American Society for Microbiology;
MinarovitsJ.,
Minarovits-KormutaS.,
Ehlin-HenrikssonB.,
FalkK.,
KleinG.,
ErnbergI.1991; Host cell phenotype-dependent methylation patterns of Epstein–Barr virus DNA. J Gen Virol 72:1591–1599[CrossRef]
MinarovitsJ.,
HuL. F.,
MarcsekZ.,
Minarovits-KormutaS.,
KleinG.,
ErnbergI.1992; RNA polymerase III-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein–Barr virus-carrying cell types. J Gen Virol 73:1687–1692[CrossRef]
MukhopadhyayR.,
YuW.,
WhiteheadJ.,
XuJ.,
LezcanoM.,
PackS.,
KanduriC.,
KanduriM.,
GinjalaV.other authors2004; The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide. Genome Res 14:1594–1602[CrossRef]
NillerH. H.,
SalamonD.,
IlgK.,
KoroknaiA.,
BanatiF.,
BaumlG.,
RückerO. L.,
SchwarzmannF.,
WolfH.,
MinarovitsJ.2003; The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein–Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. Med Sci Monit 9:1–9
OhlssonR.,
RenkawitzR.,
LobanenkovV.2001; CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet 17:520–527[CrossRef]
RobertsonK. D.,
HaywardS. D.,
LingP. D.,
SamidD.,
AmbinderR. F.1995; Transcriptional activation of the Epstein–Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol 15:6150–6159
SalamonD.,
TakacsM.,
MyöhänenS.,
MarcsekZ.,
BerencsiG.,
MinarovitsJ.2000; De novo DNA methylation at nonrandom founder sites 5′ from an unmethylated minimal origin of DNA replication in latent Epstein–Barr virus genomes. Biol Chem 381:95–105
SalamonD.,
TakacsM.,
SchwarzmannF.,
WolfH.,
MinarovitsJ.,
NillerH. H.2003; High-resolution methylation analysis and in vivo protein–DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein–Barr virus genomes. Virus Genes 27:57–66[CrossRef]
TakacsM.,
SalamonD.,
MyöhänenS.,
LiH.,
SegesdiJ.,
UjvariD.,
UhligJ.,
NillerH. H.,
WolfH.other authors2001; Epigenetics of latent Epstein–Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and latent membrane protein 2B genes. Biol Chem 382:699–705
TaoQ.,
RobertsonK. D.,
MannsA.,
HildesheimA.,
AmbinderR. F.1998; The Epstein–Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive. J Virol 72:7075–7083
WoisetschlaegerM.,
StromingerJ. L.,
SpeckS. H.1989; Mutually exclusive use of viral promoters in Epstein–Barr virus latently infected lymphocytes. Proc Natl Acad Sci U S A 86:6498–6502[CrossRef]
Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein–Barr virus is unaffected by CpG methylation and does not correlate with Cp activity